Literature DB >> 19608864

Suppressive roles of calreticulin in prostate cancer growth and metastasis.

Mahesh Alur1, Minh M Nguyen, Scott E Eggener, Feng Jiang, Soheil S Dadras, Jeffrey Stern, Simon Kimm, Kim Roehl, James Kozlowski, Michael Pins, Marek Michalak, Rajiv Dhir, Zhou Wang.   

Abstract

Calreticulin is an essential, multifunctional Ca(2+)-binding protein that participates in the regulation of intracellular Ca(2+) homeostasis, cell adhesion, and chaperoning. Calreticulin is abundantly expressed and regulated by androgens in prostate epithelial cells. Given the importance of both calreticulin in multiple essential cellular activities and androgens in prostate cancer, we investigated the possibility of a role for calreticulin in prostate cancer progression. Immunohistochemistry revealed the down-regulation of calreticulin in a subset of human prostate cancer specimens. Prostate cancer cells overexpressing exogenous calreticulin produced fewer colonies in both monolayer culture and soft agar. Furthermore, calreticulin overexpression also inhibited tumor growth in the orthotopic PC3 xenograft tumor model and macroscopic lung metastasis in the rat Dunning AT3.1 prostate tumor model. To address the potential mechanism of calreticulin suppression of prostate cancer, we generated calreticulin mutants with different functional domains deleted. The calreticulin mutants containing the P-domain, which binds to other endoplasmic reticulum chaperone proteins, were sufficient for the suppression of PC3 growth in colony formation assays. Overall, our data support the hypothesis that calreticulin inhibits growth and/or metastasis of prostate cancer cells and that this suppression requires the P-domain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19608864      PMCID: PMC2716982          DOI: 10.2353/ajpath.2009.080417

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  52 in total

Review 1.  Calreticulin.

Authors:  M Michalak; R E Milner; K Burns; M Opas
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

Review 2.  Calreticulin: one protein, one gene, many functions.

Authors:  M Michalak; E F Corbett; N Mesaeli; K Nakamura; M Opas
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

3.  Modulation of gene expression by calreticulin binding to the glucocorticoid receptor.

Authors:  K Burns; B Duggan; E A Atkinson; K S Famulski; M Nemer; R C Bleackley; M Michalak
Journal:  Nature       Date:  1994-02-03       Impact factor: 49.962

4.  Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

Authors:  M E Kaighn; K S Narayan; Y Ohnuki; J F Lechner; L W Jones
Journal:  Invest Urol       Date:  1979-07

Review 5.  Calreticulin, a Ca2+-binding chaperone of the endoplasmic reticulum.

Authors:  Pascal Gelebart; Michal Opas; Marek Michalak
Journal:  Int J Biochem Cell Biol       Date:  2005-02       Impact factor: 5.085

6.  Metastatic model for human prostate cancer using orthotopic implantation in nude mice.

Authors:  R A Stephenson; C P Dinney; K Gohji; N G Ordóñez; J J Killion; I J Fidler
Journal:  J Natl Cancer Inst       Date:  1992-06-17       Impact factor: 13.506

7.  Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers.

Authors:  J T Isaacs; W B Isaacs; W F Feitz; J Scheres
Journal:  Prostate       Date:  1986       Impact factor: 4.104

8.  Patterns of metastasis by the human prostate cancer cell line PC-3 in athymic nude mice.

Authors:  D H Shevrin; K I Gorny; S C Kukreja
Journal:  Prostate       Date:  1989       Impact factor: 4.104

9.  Suppression of prostate tumor growth by U19, a novel testosterone-regulated apoptosis inducer.

Authors:  Wuhan Xiao; Qiuheng Zhang; Feng Jiang; Michael Pins; James M Kozlowski; Zhou Wang
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

10.  Functional specialization of calreticulin domains.

Authors:  K Nakamura; A Zuppini; S Arnaudeau; J Lynch; I Ahsan; R Krause; S Papp; H De Smedt; J B Parys; W Muller-Esterl; D P Lew; K H Krause; N Demaurex; M Opas; M Michalak
Journal:  J Cell Biol       Date:  2001-08-27       Impact factor: 10.539

View more
  26 in total

1.  Changes in tumor growth and metastatic capacities of J82 human bladder cancer cells suppressed by down-regulation of calreticulin expression.

Authors:  Yi-Chien Lu; Chiung-Nien Chen; Bojeng Wang; Wen-Ming Hsu; Szu-Ta Chen; King-Jen Chang; Cheng-Chi Chang; Hsinyu Lee
Journal:  Am J Pathol       Date:  2011-06-30       Impact factor: 4.307

2.  Upregulation of androgen-responsive genes and transforming growth factor-β1 cascade genes in a rat model of non-bacterial prostatic inflammation.

Authors:  Yasuhito Funahashi; Katherine J O'Malley; Naoki Kawamorita; Pradeep Tyagi; Donald B DeFranco; Ryosuke Takahashi; Momokazu Gotoh; Zhou Wang; Naoki Yoshimura
Journal:  Prostate       Date:  2013-12-17       Impact factor: 4.104

3.  Calreticulin is a novel independent prognostic factor for oral squamous cell carcinoma.

Authors:  Koji Harada; Takanori Takenawa; Tarannum Ferdous; Yasuhiro Kuramitsu; Yoshiya Ueyama
Journal:  Oncol Lett       Date:  2017-04-20       Impact factor: 2.967

4.  Cancer Biology of the Endoplasmic Reticulum Lectin Chaperones Calreticulin, Calnexin and PDIA3/ERp57.

Authors:  Shing Tat Theodore Lam; Chinten James Lim
Journal:  Prog Mol Subcell Biol       Date:  2021

5.  Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial-to-mesenchymal transition.

Authors:  Shing-Hwa Liu; Wen-Jane Lee; De-Wei Lai; Sheng-Mao Wu; Chia-Yu Liu; Hsing-Ru Tien; Chien-Shan Chiu; Yen-Chun Peng; Yee-Jee Jan; Te-Hsin Chao; Hung-Chuan Pan; Meei-Ling Sheu
Journal:  Mol Oncol       Date:  2015-01-06       Impact factor: 6.603

6.  Protein signatures to distinguish aggressive from indolent prostate cancer.

Authors:  Fernando Garcia-Marques; Shiqin Liu; Sarah M Totten; Abel Bermudez; Cheylene Tanimoto; En-Chi Hsu; Rosalie Nolley; Amy Hembree; Tanya Stoyanova; James D Brooks; Sharon J Pitteri
Journal:  Prostate       Date:  2022-01-31       Impact factor: 4.104

7.  5α-reductase inhibition suppresses testosterone-induced initial regrowth of regressed xenograft prostate tumors in animal models.

Authors:  Khalid Z Masoodi; Raquel Ramos Garcia; Laura E Pascal; Yujuan Wang; Hei M Ma; Katherine O'Malley; Kurtis Eisermann; Daniel H Shevrin; Holly M Nguyen; Robert L Vessella; Joel B Nelson; Rahul A Parikh; Zhou Wang
Journal:  Endocrinology       Date:  2013-05-13       Impact factor: 4.736

Review 8.  Calreticulin and cancer.

Authors:  Mohammadreza Zamanian; Abhi Veerakumarasivam; Syahril Abdullah; Rozita Rosli
Journal:  Pathol Oncol Res       Date:  2013-02-08       Impact factor: 3.201

9.  Study on the Role of Calreticulin Within Platelet from Adult Patients with Chronic Immune Thrombocytopenic Purpura.

Authors:  Kam Chau Yung; Ze Wen Zhang; Wen Jun Yu; Jin Feng Qiu; Cheng Wei Xu; Chun Ling He; Xian Ru Xu; Jun Yin
Journal:  Indian J Hematol Blood Transfus       Date:  2018-04-02       Impact factor: 0.900

Review 10.  Calreticulin and cancer.

Authors:  Jitka Fucikova; Radek Spisek; Guido Kroemer; Lorenzo Galluzzi
Journal:  Cell Res       Date:  2020-07-30       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.